Most Recent
Essure contraceptive ‘safe and efficacious’, Bayer tells class action trial
Bayer told a jury that clinical trials from the 1990’s to 2014 showed its Essure birth control device was “safe and efficacious”, as the pharmaceutical giant faces trial in a class action by patients who claim they suffered debilitating injuries from the device.
ACCC says it’s too late for regrets in BlueScope price-fixing case
BlueScope Steel spent $27 million defending the ACCC's claims that it engaged in serious cartel conduct in relation to the supply of flat steel products in Australia, and its apologies came too late to warrant a penalty discount, a court has heard.
Lachlan Murdoch ‘morally and ethically culpable’ for US Capitol riot, Crikey publisher says
Crikey publisher Private Media has filed a new contextual truth defence to defamation claims brought by Lachlan Murdoch, arguing the Fox News CEO is "morally and ethically culpable" for the January 6 riot on the US Capitol.
High Court dashes Spain’s challenge to sovereign immunity claims in $394M dispute
Spain has lost its High Court appeal arguing it had sovereign immunity from an Australian court’s recognition of a $394 million arbitration award against the country for changes to its energy policies. 
Ex-Cushman & Wakefield director says $1.3M sign-on bonus with rival at stake in employment case
A court has heard that a director at office leasing company Cushman & Wakefield who accepted a job with a competitor could lose a $1.3 million sign-on bonus if the case by her former employer is not promptly resolved.
Bayer can’t dismiss Essure injuries as ‘common women’s symptoms’, class action trial told
Pharmaceutical giant Bayer cannot write off debilitating chronic pain and bleeding which patients allegedly experienced after being implanted with Essure contraceptives as “common women's symptoms”, a court has heard in the first day of trial in a long-running class action.
Decision looming on Lehrmann defamation cases against News Corp, Ten
Accused rapist Bruce Lehrmann will learn this week whether his defamation cases against News Corp and Network Ten can proceed despite the expiration of a 12-month limitations period.
Mecca’s distribution agreement with lux cosmetics brand not unlawful, court finds
Beauty giant Mecca has succeeded in fending off a luxury cosmetics brand's appeal of a decision that found a term of an exclusive distribution agreement between them was not an unlawful restraint of trade.
‘Unjustifiable threats’: TCT Group wins patent revocation, indemnity costs against Polaris
TCT Group has won orders revoking two patents for hinges held by Polaris IP as well as indemnity costs, with a judge finding the patentee made “unjustifiable” threats of infringement against TCT over its own brand of soft-close glass hinges.
App store class action funder can’t see evidence in Epic’s case against Apple
The litigation funder bankrolling two competition class actions against Apple and Google has lost its bid to see evidence filed in a similar case by developer Epic Games, after concerns were raised about its potential use in overseas proceedings against Apple.